Jacobi J, Fraser GL, Coursin DB, Riker RR, Fontaine D, Wittbrodt ET, et al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med 2002;30(1):119–141. DOI: 10.1097/00003246-200201000-00020.
Barr J, Fraser GL, Puntillo K, Ely EW, Gélinas C, Dasta JF, et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med 2013;41(1):263–306. DOI: 10.1097/CCM.0b013e3182783b72.
Devlin JW, Skrobik Y, Gélinas C, Needham DM, Slooter AJC, Pandharipande PP, et al. Clinical practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU. Crit Care Med 2018;46(9):e825–e873. DOI: 10.1097/CCM.0000000000003299.
Shehabi Y, Bellomo R, Mehta S, Riker R, Takala J. Intensive care sedation: the past, present and the future. Crit Care 2013;17(3):1–7. DOI: 10.1186/cc12679.
Kollef MH, Levy NT, Ahrens TS, Schaiff R, Prentice D, Sherman G. The use of continuous i.v. sedation is associated with prolongation of mechanical ventilation. Chest 1998;114(2):541–548. DOI: 10.1378/chest.114.2.541.
Watson PL, Shintani AK, Tyson R, Pandharipande PP, Pun BT, Ely EW. Presence of electroencephalogram burst suppression in sedated, critically ill patients is associated with increased mortality. Crit Care Med 2008;36(12):3171–3177. DOI: 10.1097/CCM.0b013e318186b9ce.
Girard TD, Shintani AK, Jackson JC, Gordon SM, Pun BT, Henderson MS, et al. Risk factors for post-traumatic stress disorder symptoms following critical illness requiring mechanical ventilation: a prospective cohort study. Crit Care 2007;11(1):R28. DOI: 10.1186/cc5708.
Pandharipande PP, Pun BT, Herr DL, Maze M, Girard TD, Miller RR, et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA 2007;298(22):2644–2653. DOI: 10.1001/jama.298.22.2644.
Preckel B, Bolten J. Pharmacology of modern volatile anaesthetics. Best Pract Res Clin Anaesthesiol 2005;19(3):331–348. DOI: 10.1016/j.bpa.2005.01.003.
Bierman MI, Brown M, Muren O, Keenan RL, Glauser FL. Prolonged isoflurane anesthesia in status asthmaticus. Crit Care Med 1986; 14(9):832–833. DOI: 10.1097/00003246-198609000-00017.
Mirsattari SM, Sharpe MD, Young GB. Treatment of refractory status epilepticus with inhalational anesthetic agents isoflurane and desflurane. Arch Neurol 2004;61(8):1254–1259. DOI: 10.1001/archneur.61.8.1254.
Kikuchi C, Dosenovic S, Bienengraeber M. Anaesthetics as cardioprotectants: translatability and mechanism. Br J Pharmacol 2015;172(8):2051–2061. DOI: 10.1111/bph.12981.
Kim M, Park SW, Kim M, D'Agati VD, Lee HT. Isoflurane post-conditioning protects against intestinal ischemia-reperfusion injury and multiorgan dysfunction via transforming growth factor-b1 generation. Ann Surg 2012;255(3):492–503. DOI: 10.1097/SLA.0b013e3182441767.
Beck-Schimmer B, Breitenstein S, Urech S, De Conno E, Wittlinger M, Puhan M, et al. A randomized controlled trial on pharmacological preconditioning in liver surgery using a volatile anesthetic. Ann Surg 2008;248(6):909–918. DOI: 10.1097/SLA.0b013e31818f3dda.
Jerath A, Panckhurst J, Parotto M, Lightfoot N, Wasowicz M, Ferguson ND, et al. Safety and efficacy of volatile anesthetic agents compared with standard intravenous midazolam/propofol sedation in ventilated critical care patients: a meta-analysis and systematic review of prospective trials. Anesth Analg 2017;124(4):1190–1199. DOI: 10.1213/ANE.0000000000001634.
Lassen HC, Henriksen E, Neukirch F, Kristensen H. Treatment of Tetanus. Severe bone-marrow depression after prolonged nitrous-oxide anaesthesia. Lancet 1956;270(6922):527–530. DOI: 10.1016/s0140-6736(56)90593-1.
Enlund M, Wiklund L, Lambert H. A new device to reduce the consumption of a halogenated anaesthetic agent. Anaesthesia 2001;56(5):429–432. DOI: 10.1046/j.1365-2044.2001.01900.x.
Bomberg H, Glas M, Groesdonk VH, Bellgardt M, Schwarz J, Volk T, et al. A novel device for target controlled administration and reflection of desflurane—the MirusTM. Anaesthesia 2014;69(11):1241–1250. DOI: 10.1111/anae.12798.
Kong KL, Willatts SM, Prys-Roberts C. Isoflurane compared with midazolam for sedation in the intensive care unit. BMJ 1989;298(6683):1277–1280. DOI: 10.1136/bmj.298.6683.1277.
Jerath A, Beattie SW, Chandy T, Karski J, Djaiani G, Rao V, et al. Volatile-based short-term sedation in cardiac surgical patients: a prospective randomized controlled trial. Crit Care Med 2015;43(5):1062–1069. DOI: 10.1097/CCM.0000000000000938.
Sackey PV, Martling CR, Granath F, Radell PJ. Prolonged isoflurane sedation of intensive care unit patients with the Anesthetic Conserving Device. Crit Care Med 2004;32(11):2241–2246. DOI: 10.1097/01.ccm.0000145951.76082.77.
Röhm KD, Mengistu A, Boldt J, Mayer J, Beck G, Piper SN. Renal integrity in sevoflurane sedation in the intensive care unit with the anesthetic-conserving device: a comparison with intravenous propofol sedation. Anesth Analg 2009;108(6):1848–1854. DOI: 10.1213/ane.0b013e3181a1988b.
Kulkarni AP, Bhosale SJ, Kalvit KR, Sahu TK, Mohanty R, Dhas MM, et al. Safety and feasibility of AnaConDa™ to deliver inhaled isoflurane for sedation in patients undergoing elective postoperative mechanical ventilation: A prospective, open-label, interventional trial (INSTINCT I Study). Indian J Crit Care Med 2022;26(8):906–912.
